ArticleParasite epidemiology and control2025
Magnitude of urban malaria and its associated risk factors in Damboya town, Kambata zone, Central Ethiopia.
Article in Parasite epidemiology and control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Prevalence and associated factors of microscopy-confirmed malaria among the general population in Ethiopia: a systematic review and meta-analysis.Malaria journal · 2026Pooled it
- Urban malaria and population mobility in sub-Saharan Africa: systematic review and meta-analysis.Malaria journal · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As Sub-Saharan African country urban malaria is potential catastrophe in Ethiopia, particularly in relation to rapidly growing small towns, which requires updating the epidemiology of malaria. There was lack of information regarding the study area, hence this study was designed to determine the prevalence of malaria and associated risk factors in Damboya town. Methods: A Community-based cross-sectional study was carried from March 7 to May 29, 2023 among 422 randomly selected participants. Prevalence of malaria was determined using microscopic examination of thick and thin smear and rapid diagnostic test using kits to standard of the manufacturer. Pretested structured questionnaire was employed to collect socio-demographic data and associated risk factors. Data were entered in Epi data 3.1 and analyzed using SPSS version 25 software. Factors associated with malaria was analyzed using bivariable and multivariable binary logistic regression. The strength of the association was determined by computing Adjusted Odds Ratio (AOR) at Malaria is one of the most vital leading cause of morbidity and mortality in developing countries particularly in Sub Saharan Africa (Bugssa and Tedla, 2020). About 95 % of all malaria cases and 96 % of all malaria deaths in 2021 occurred in Africa (Bugssa and Tedla, 2020). Sub-Saharan Africa accounted for 60 % of global cases and 90 % of global fatalities (WHO, 2022). Over the two peak years of the pandemic (2020-2021), COVID-related setbacks increased malaria cases by around 13 million and fatalities by 63,000 (WHO, 2022). Malaria is thought to directly cost Africa $12 billion annually and reduce GDP growth by 3 %. In addition, it is thought to cause cognitive disorders and school absences, which are barriers to the development of human capital (Monroe et al., 2022). 95 % confidence interval (CI) and Result: The prevalence of malaria was 5 % (20, 95 % CI: 3-7), Conclusion: Malaria is still a public health concern in Damboya town. Thus, implementing intervention strategies properly and evaluate the access and utilization status of the suburb community and improve accordingly was required to interrupt the transmission in the community of this town.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.